Conclusion of non-exclusive discount agreements in accordance with § 130 a para. 8 SGB V with the possibility of conclusion at any time within the framework of so-called "OpenHouse procedures" for various active pharmaceutical ingredients with the earliest possible start of the contract on 01.10.2023.
,
The specific active pharmaceutical ingredients and the respective contract starts can be found in the current list of active pharmaceutical ingredients in the project area of the dtvp procurement portal under the heading "Procurement documents".
,
As of 01.10.2023, contracts will be offered for the following active ingredients:
,
Dapagliflozin
Eisencarboxymaltose
Fluorouracil exclusively dosage form cream
Sapropterin
Somatropin
Tafluprost
Tafluprost/Timolol
tamoxifen
,
The contracts will end uniformly on 30.09.2025.
AOK Rheinland/Hamburg announces the conclusion of non-exclusive discount agreements in accordance with § 130 a para. 8 SGB V with the possibility of conclusion at any time within the framework of so-called "OpenHouse procedures" for various active pharmaceutical ingredients with the earliest possible start of the contract on 01.10.2023.
,
The specific active pharmaceutical ingredients and the respective, earliest possible contract starts can be found in the current list of active pharmaceutical ingredients in the project area of the dtvp procurement portal under the heading "Procurement documents".
,
Providing uniform contractual conditions and a uniform access procedure, all suitable and interested pharmaceutical companies or communities of pharmaceutical companies are offered the conclusion or entry to a discount contract in accordance with Section 130a (8) SGB V.
,
Interested pharmaceutical companies can obtain the participation documents in the project room of the DTVP procurement portal under the heading "Procurement documents".
,
The prerequisite for the conclusion of a contract is that the interested pharmaceutical company sends the requested participation documents completely completed and signed to the following e-mail inbox:
,
open-house@rh.aok.de.
,
This e-mail inbox is used for any exchange of documents and documents for the implementation of the OpenHouse procedure between the companies and the medicinal products division of AOK Rheinland/Hamburg.
,
A contract is concluded with every pharmaceutical company that meets the eligibility requirements. There is no exclusivity. The accession or the conclusion of the contract can take place at any time and under the same conditions. Individual contract negotiations are not conducted.
,
The earliest start of the contract is 01.10.2023. It is possible to conclude or join a discount contract at any time, i.e. even after 01.10.2023. The contract period ends uniformly on 30.09.2025, regardless of the individual start of the contract.
,
The list of the contractually active substances is changed at irregular intervals. In this case, all companies verified in the project room in the DTVP award portal will receive an email with information about which active ingredients have been added and when the earliest possible start of the contract is.
Should AOK Rheinland/Hamburg carry out a tender for exclusive contracts in the form of an EU-wide, open procedure during the term of the contract, the contracts concluded within the framework of this publication will be terminated in accordance with the contractual provisions.
,
This publication is not about awarding a public contract within the meaning of the public procurement coordination directive (2014/24 / EG) or public procurement law. In order to ensure the highest level of transparency for the intended contracts, the publication is published in the supplement to the Official Journal of the European Union. In the absence of a corresponding publication form, the contract notice will be used.
,
The resulting conceptual requirements, such as the procedure designation "open procedure", are solely due to the use of this announcement form and the publication platform. A further significance, in particular a submission to procurement law regulations, insofar as they are not obliged for legal reasons, is not associated with this.